Review



pcsk9  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Boster Bio pcsk9
    Full fabrication and application schematic diagram of <t>GelMA-VEGF/ECM-PCSK9</t> composite hydrogel and the related signaling pathway of PCSK9 that promotes BMSC osteogenic differentiation.
    Pcsk9, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/Human+PCSK9+ELISA+Kit+EZ-Set/pmc13019078-69-6-10
    Average 94 stars, based on 2 article reviews
    pcsk9 - by Bioz Stars, 2026-11
    94/100 stars

    Images

    1) Product Images from "A composite hydrogel enables the spatiotemporal delivery of distinct cytokines to drive the native vascularized bone regeneration"

    Article Title: A composite hydrogel enables the spatiotemporal delivery of distinct cytokines to drive the native vascularized bone regeneration

    Journal: Bioactive Materials

    doi: 10.1016/j.bioactmat.2026.02.048

    Full fabrication and application schematic diagram of GelMA-VEGF/ECM-PCSK9 composite hydrogel and the related signaling pathway of PCSK9 that promotes BMSC osteogenic differentiation.
    Figure Legend Snippet: Full fabrication and application schematic diagram of GelMA-VEGF/ECM-PCSK9 composite hydrogel and the related signaling pathway of PCSK9 that promotes BMSC osteogenic differentiation.

    Techniques Used:

    Construction and characterization of GelMA-VEGF/ECM-PCSK9 composite hydrogel. A Schematic diagram showing the process of composite hydrogel construction; B) Photographs of GelMA-VEGF hydrogel and GelMA-VEGF/ECM-PCSK9 hydrogel formation after UV light respectively; C i) Electron microscopic image of pure GelMA hydrogel, with a scale of 100 μm; ii) Enlarged electron microscopic image of GelMA hydrogel, with a scale of 50 μm; D) i The electron microscope image of the combination of GelMA hydrogel and ECM, with a scale of 100 μm; ii Electron microscope magnified image of GelMA hydrogel combined with ECM, with a scale of 50 μm; E) The infrared spectrum (FITR) diagram of the acellular ECM, GelMA hydrogel and GelMA/ECM composite hydrogel contains common basic energy groups; F) Load rate of PCSK9 in ECM; G) Release rate of VEGF loaded with GelMA hydrogel and GelMA/ECM composite hydrogel respectively; H) Release rate of PCSK9 loaded with ECM and GelMA/ECM composite hydrogel respectively; I) Release rate of VEGF and PCSK9 loaded in GelMA and GelMA/ECM on different time points respectively; J) Release rate of VEGF and PCSK9 respectively when loaded in GelMA/ECM; K) The swelling rate of GelMA gel and GelMA/ECM composite gel dissolved in PBS (n = 6); L) Degradation rate of GelMA hydrogel and GelMA/ECM composite gel in vitro (n = 6).∗means that compared with the control group, p < 0.05; ∗means that compared with the control group, p < 0.01; ∗∗∗means that compared with the control group, p < 0.001.
    Figure Legend Snippet: Construction and characterization of GelMA-VEGF/ECM-PCSK9 composite hydrogel. A Schematic diagram showing the process of composite hydrogel construction; B) Photographs of GelMA-VEGF hydrogel and GelMA-VEGF/ECM-PCSK9 hydrogel formation after UV light respectively; C i) Electron microscopic image of pure GelMA hydrogel, with a scale of 100 μm; ii) Enlarged electron microscopic image of GelMA hydrogel, with a scale of 50 μm; D) i The electron microscope image of the combination of GelMA hydrogel and ECM, with a scale of 100 μm; ii Electron microscope magnified image of GelMA hydrogel combined with ECM, with a scale of 50 μm; E) The infrared spectrum (FITR) diagram of the acellular ECM, GelMA hydrogel and GelMA/ECM composite hydrogel contains common basic energy groups; F) Load rate of PCSK9 in ECM; G) Release rate of VEGF loaded with GelMA hydrogel and GelMA/ECM composite hydrogel respectively; H) Release rate of PCSK9 loaded with ECM and GelMA/ECM composite hydrogel respectively; I) Release rate of VEGF and PCSK9 loaded in GelMA and GelMA/ECM on different time points respectively; J) Release rate of VEGF and PCSK9 respectively when loaded in GelMA/ECM; K) The swelling rate of GelMA gel and GelMA/ECM composite gel dissolved in PBS (n = 6); L) Degradation rate of GelMA hydrogel and GelMA/ECM composite gel in vitro (n = 6).∗means that compared with the control group, p < 0.05; ∗means that compared with the control group, p < 0.01; ∗∗∗means that compared with the control group, p < 0.001.

    Techniques Used: Microscopy, In Vitro, Control

    Angiogenic capacity formulations of HUVECs in response to different composite biomaterial in vitro. A) Calcein/PI staining of HUVECs seeded on glass slides, showing the cell migration profiles of HUVECs treated with different material groups, scale bar = 200 μm; B) Quantitative analysis of the intercellular blank areas in each group, with the baseline group serving as the negative control; C) Angiogenic images of HUVECs co-cultured with different composite materials for 4 h and 8 h respectively, scale bar = 250 μm; D–G) Quantitative assessment of angiogenic capacity in each group via ImageJ software analysis of key angiogenic parameters. Abbreviations: NC = negative control group; V = exogenous VEGF protein-only group; GV=GelMA + exogenous VEGF protein group; GVE = GelMA + VEGF + ECM group; GVEP= GelMA/VEGF + ECM/PCSK9 group. Statistical notations: ∗∗means that compared with the control group, p < 0.01; ns = no significant difference between group.
    Figure Legend Snippet: Angiogenic capacity formulations of HUVECs in response to different composite biomaterial in vitro. A) Calcein/PI staining of HUVECs seeded on glass slides, showing the cell migration profiles of HUVECs treated with different material groups, scale bar = 200 μm; B) Quantitative analysis of the intercellular blank areas in each group, with the baseline group serving as the negative control; C) Angiogenic images of HUVECs co-cultured with different composite materials for 4 h and 8 h respectively, scale bar = 250 μm; D–G) Quantitative assessment of angiogenic capacity in each group via ImageJ software analysis of key angiogenic parameters. Abbreviations: NC = negative control group; V = exogenous VEGF protein-only group; GV=GelMA + exogenous VEGF protein group; GVE = GelMA + VEGF + ECM group; GVEP= GelMA/VEGF + ECM/PCSK9 group. Statistical notations: ∗∗means that compared with the control group, p < 0.01; ns = no significant difference between group.

    Techniques Used: In Vitro, Staining, Migration, Negative Control, Cell Culture, Software, Control

    The effect of different composite hydrogel on the osteogenic differentiation of BMMSC in vitro. Cultivate BMMSC for osteogenic differentiation in osteogenic medium with GelMA, GelMA-VEGF, GelMA-VEGF/ECM, ECM-PCSK9, and GelMA-VEGF/ECM-PCSK9 for 7 days respectively. A,B) The cell nucleus was stained with DAPI (blue), RUNX2 was stained with RUNX2 antibody (green), and COL1A1 was stained with COL1A1 antibody (red), with a scale bar of 200 μm. C,D) The quantitative analysis results of COL1A1 and RUNX2 immunofluorescence images; E,F) Quantitative analysis of ALP staining and ARS staining for BMMSC co-culture with different kinds of hydrogels; G) ALP staining result for BMMSC co-culture with different kinds of hydrogels for 7days, scale bar = 200 μm; F) ARS staining result for BMMSC co-culture with different kinds of hydrogels for 14days, scale bar = 200 μm; I, J) After 7 and 14 days of co-culture with different combinations of composite hydrogels and BMMSC for osteogenesis and differentiation, the PCR experiment results of osteogenesis related indicators suggest that compared with the control group. G = simple GelMA hydrogel group, GV=GelMA hydrogels + VEGF protein group, GV/E = GelMA + VEGF/ECM group, EP = ECM + PCSK9 protein group, GVEP=GelMA + VEGF/ECM + PCSK9 protein group, the significant differences between the groups are expressed as ∗ p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ns means there is no significant difference between the groups.
    Figure Legend Snippet: The effect of different composite hydrogel on the osteogenic differentiation of BMMSC in vitro. Cultivate BMMSC for osteogenic differentiation in osteogenic medium with GelMA, GelMA-VEGF, GelMA-VEGF/ECM, ECM-PCSK9, and GelMA-VEGF/ECM-PCSK9 for 7 days respectively. A,B) The cell nucleus was stained with DAPI (blue), RUNX2 was stained with RUNX2 antibody (green), and COL1A1 was stained with COL1A1 antibody (red), with a scale bar of 200 μm. C,D) The quantitative analysis results of COL1A1 and RUNX2 immunofluorescence images; E,F) Quantitative analysis of ALP staining and ARS staining for BMMSC co-culture with different kinds of hydrogels; G) ALP staining result for BMMSC co-culture with different kinds of hydrogels for 7days, scale bar = 200 μm; F) ARS staining result for BMMSC co-culture with different kinds of hydrogels for 14days, scale bar = 200 μm; I, J) After 7 and 14 days of co-culture with different combinations of composite hydrogels and BMMSC for osteogenesis and differentiation, the PCR experiment results of osteogenesis related indicators suggest that compared with the control group. G = simple GelMA hydrogel group, GV=GelMA hydrogels + VEGF protein group, GV/E = GelMA + VEGF/ECM group, EP = ECM + PCSK9 protein group, GVEP=GelMA + VEGF/ECM + PCSK9 protein group, the significant differences between the groups are expressed as ∗ p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ns means there is no significant difference between the groups.

    Techniques Used: In Vitro, Staining, Immunofluorescence, Co-Culture Assay, Control

    After adding different concentrations of PCSK9 to BMMSC for osteogenic induction, western blotting (WB) experiment was performed to evaluate the expression of phosphorylated proteins and total proteins among different osteogenic differentiation relevant signaling pathways. A) WB images of different signaling pathways that related to osteogenic differentiation after adding different concentrations of PCSK9; B-D) Quantitative analysis results of phosphorylated protein and total protein. Compared with the control group, ∗ means p < 0.05, ∗∗ means p < 0.01.
    Figure Legend Snippet: After adding different concentrations of PCSK9 to BMMSC for osteogenic induction, western blotting (WB) experiment was performed to evaluate the expression of phosphorylated proteins and total proteins among different osteogenic differentiation relevant signaling pathways. A) WB images of different signaling pathways that related to osteogenic differentiation after adding different concentrations of PCSK9; B-D) Quantitative analysis results of phosphorylated protein and total protein. Compared with the control group, ∗ means p < 0.05, ∗∗ means p < 0.01.

    Techniques Used: Western Blot, Expressing, Protein-Protein interactions, Control

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: A composite hydrogel enables the spatiotemporal delivery of distinct cytokines to drive the native vascularized bone regeneration
    Article Snippet: .. VEGF, ELISA kit for VEGF and PCSK9 were purchased from Boster company (Wuhan, China). .. PicoGreen DNA detection kit was purchased from Thermo Fisher company (America), Vascular matrix adhesive was purchased from Biosystems(Beijing, China).CCK8, ALP staining, bicinchoninic acid (BCA) assay kit, Dil was purchased from Beyotime Biotechnology (Shanghai, China).

    Article Title: A composite hydrogel enables the spatiotemporal delivery of distinct cytokines to drive the native vascularized bone regeneration
    Article Snippet: .. VEGF, ELISA kit for VEGF and PCSK9 were purchased from Boster company (Wuhan, China). .. PicoGreen DNA detection kit was purchased from Thermo Fisher company (America), Vascular matrix adhesive was purchased from Biosystems(Beijing, China).CCK8, ALP staining, bicinchoninic acid (BCA) assay kit, Dil was purchased from Beyotime Biotechnology (Shanghai, China).



    Similar Products

    95
    Zymo Research dnase i
    Dnase I, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/DNase+I+Set+w%2F+DNA+Digestion+Buffer/pmc13759040-139-4-7
    Average 95 stars, based on 1 article reviews
    dnase i - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    98
    Complete Genomics Inc dnbseq t7rs platform
    Dnbseq T7rs Platform, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/FCL+PE100+Sequencing+Set+V1%2E0/pm42956743-1026-7--1
    Average 98 stars, based on 1 article reviews
    dnbseq t7rs platform - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    90
    Occlutech GmbH delivery set (ods
    Delivery Set (Ods, supplied by Occlutech GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/delivery+set++ods/nct05264753-0-29-29
    Average 90 stars, based on 1 article reviews
    delivery set (ods - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    96
    Illumina Inc truseq small rna sample prep kit
    Truseq Small Rna Sample Prep Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/TruSeq+Small+RNA+Library+Prep+Kit+-Set+A/pm42998579-66-8-14
    Average 96 stars, based on 1 article reviews
    truseq small rna sample prep kit - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    Complete Genomics Inc mgieasy universal dna library prep set
    Mgieasy Universal Dna Library Prep Set, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/MGIEasy+Universal+DNA+Library+Prep+Set%2C+96+RNX/pmc13752511-56-0-9
    Average 98 stars, based on 1 article reviews
    mgieasy universal dna library prep set - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    94
    Sino Biological mouse il 6 elisa kit
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Mouse Il 6 Elisa Kit, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/Mouse+IL6ST+%2F+gp130+%2F+CD130+ELISA+Pair+Set/pmc13752232-299-7-14
    Average 94 stars, based on 1 article reviews
    mouse il 6 elisa kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Carl Zeiss filter set 92 he led
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Filter Set 92 He Led, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/Filter+set+92+HE+LED+(E)/pm42790276-76-25-30
    Average 96 stars, based on 1 article reviews
    filter set 92 he led - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    Complete Genomics Inc mgieasy rna library prep set
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Mgieasy Rna Library Prep Set, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/MGIEasy+Fast+RNA+Library+Prep+Set/pmc13764288-329-6-22
    Average 98 stars, based on 1 article reviews
    mgieasy rna library prep set - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    96
    World Precision Instruments stx 2 electrodes
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Stx 2 Electrodes, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/Chopstick+Electrode+Set+for+EVOM2%2C+-+DISCONTINUED/pm42988245-50-24-27
    Average 96 stars, based on 1 article reviews
    stx 2 electrodes - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Illumina Inc truseq small rna library preparation kits
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Truseq Small Rna Library Preparation Kits, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/TruSeq+Small+RNA+Library+Prep+Kit+-Set+A/pm42992648-129-14-29
    Average 96 stars, based on 1 article reviews
    truseq small rna library preparation kits - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, Il‐6, Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, Il‐6, Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: Serum IL‐6 levels were measured using a mouse IL‐6 ELISA kit ( SEK50135 , Sino Biological Inc.).

    Techniques: In Vitro, Inhibition, Labeling, Analysis, Expressing, Fluorescence, Cell Culture, Exosomes, Quantitative RT-PCR, Flow Cytometry, Western Blot, Derivative Assay

    NANP modulates the miRNA content in exosomes through the upregulation of SMPD3. (A) Volcano plot showing the differential expression analysis of miRNAs between MSCs‐exo and NAD + ‐loaded MSCs‐exo. (B) GO analysis of significantly enriched genes in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (C) Heatmap illustrating the upregulation of miRNAs in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (D) qRT‐PCR analysis of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p expression in exosomes from MSCs treated with or without NANP. (E) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, followed by transfection with siRNA‐ctrl or a combination of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p mimics (miR‐30a/146a/146b) for an additional 24 h. The mRNA expressions of the Tnf‐a , Il‐6 , Nos2 , and Il‐10 genes were detected using qRT‐PCR ( n = 3). (F) The mRNA expressions of Hnrnpa2b1 , Smpd3 , Anxa2 , Ybx1 , and Syncrip of MSCs with or without 25 µM NANP treatment for 48 h ( n = 3). (G) Protein levels of SMPD3 and YBX1 in MSCs with or without NANP (25 µM, 48 h) treatment. (H) Western blot and qRT‐PCR showing that MSCs with shRNA‐mediated SMPD3 knockdown (MSCs‐sh‐Smpd3) fail to respond to NANP‐induced SMPD3 upregulation. (I) Western blot analysis of the exosomal markers TSG101 and CD81 detected in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 cells. (J) The expression of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 in the presence or absence of NANP, measured by qRT‐PCR ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: NANP modulates the miRNA content in exosomes through the upregulation of SMPD3. (A) Volcano plot showing the differential expression analysis of miRNAs between MSCs‐exo and NAD + ‐loaded MSCs‐exo. (B) GO analysis of significantly enriched genes in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (C) Heatmap illustrating the upregulation of miRNAs in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (D) qRT‐PCR analysis of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p expression in exosomes from MSCs treated with or without NANP. (E) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, followed by transfection with siRNA‐ctrl or a combination of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p mimics (miR‐30a/146a/146b) for an additional 24 h. The mRNA expressions of the Tnf‐a , Il‐6 , Nos2 , and Il‐10 genes were detected using qRT‐PCR ( n = 3). (F) The mRNA expressions of Hnrnpa2b1 , Smpd3 , Anxa2 , Ybx1 , and Syncrip of MSCs with or without 25 µM NANP treatment for 48 h ( n = 3). (G) Protein levels of SMPD3 and YBX1 in MSCs with or without NANP (25 µM, 48 h) treatment. (H) Western blot and qRT‐PCR showing that MSCs with shRNA‐mediated SMPD3 knockdown (MSCs‐sh‐Smpd3) fail to respond to NANP‐induced SMPD3 upregulation. (I) Western blot analysis of the exosomal markers TSG101 and CD81 detected in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 cells. (J) The expression of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 in the presence or absence of NANP, measured by qRT‐PCR ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: Serum IL‐6 levels were measured using a mouse IL‐6 ELISA kit ( SEK50135 , Sino Biological Inc.).

    Techniques: Exosomes, Quantitative Proteomics, Analysis, Quantitative RT-PCR, Expressing, Transfection, Western Blot, shRNA, Knockdown, Derivative Assay, Cell Surface Receptor Assay, Gene Expression